Biotech · Public company · Boston, MA, US
Atea Pharmaceuticals, Inc.
Ticker AVIR · SEC CIK 0001593899
Track this companyFree. Adds Atea Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials120 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline22
- Bemnifosbuvir (BEM)Phase 3 · Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection)ClinicalTrials.gov · fetched Nov 12, 2026
- Bemnifosbuvir-Ruzasvir (BEM/RZR)Phase 3 · HEPATITIS C VIRUS CHRONIC INFECTIONClinicalTrials.gov · fetched Nov 12, 2026
- Sofosbuvir-Velpatasvir (SOF/VEL)Phase 3 · HEPATITIS C VIRUS CHRONIC INFECTIONClinicalTrials.gov · fetched Nov 12, 2026
- AT-527Phase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- BemnifosbuvirPhase 2 · Chronic Hepatitis C VirusClinicalTrials.gov · fetched Nov 12, 2026
- RuzasvirPhase 2 · Chronic Hepatitis C VirusClinicalTrials.gov · fetched Nov 12, 2026
- AT-527 (R07496998)Phase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- AT-752Phase 1 · DengueClinicalTrials.gov · fetched Nov 12, 2026
- Bemnifosbuvir (BEM)Phase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Bemnifosbuvir (BEM)Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- Bemnifosbuvir (BEM) and Ruzasvir (RZR) as reference formulation under fasting conditionsPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Bemnifosbuvir (BEM)/Ruzasvir (RZR) as a fixed-dose combinationPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditionsPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fed conditionsPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Buprenorphine/Naloxone + BEM/RZRPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Methadone +BEM/RZRPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Treatment A-Bemnifosbuvir/Ruzasvir FDC administered fastingPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Treatment B-Omeprazole 20 mg dose administered fastingPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Treatment C-Bemnifosbuvir/Ruzasvir FDC administered simultaneously with 20 mg dose of Omeprazole fastingPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Treatment D-Bemnifosbuvir/Ruzasvir FDC administered 0.5 hour prior to 20 mg dose of OmeprazolePhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Treatment E-Omeprazole 40 mg administered fastingPhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
- Treatment F-Bemnifosbuvir/Ruzasvir FDC administered 2 hours after 40 mg dose OmeprazolePhase 1 · Healthy Volunteer StudyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/RuzasvirPHASE1 · COMPLETED · started May 9, 2025ClinicalTrials.gov NCT07007806 · fetched Nov 12, 2026
- Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic FunctionPHASE1 · COMPLETED · started Apr 9, 2025ClinicalTrials.gov NCT06911320 · fetched Nov 12, 2026
- C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCVPHASE3 · COMPLETED · started Apr 7, 2025ClinicalTrials.gov NCT06868264 · fetched Nov 12, 2026
- Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or MethadonePHASE1 · COMPLETED · started Jan 7, 2025ClinicalTrials.gov NCT07314346 · fetched Nov 12, 2026
- Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and RuzasvirPHASE1 · COMPLETED · started Dec 14, 2023ClinicalTrials.gov NCT06204679 · fetched Nov 12, 2026
- A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVPHASE2 · COMPLETED · started May 30, 2023ClinicalTrials.gov NCT05904470 · fetched Nov 12, 2026
- The Study of Bemnifosbuvir in Healthy Japanese SubjectsPHASE1 · COMPLETED · started Apr 26, 2023ClinicalTrials.gov NCT05905497 · fetched Nov 12, 2026
- Study of Bemnifosbuvir in Subjects With Normal and Impaired Hepatic FunctionPHASE1 · COMPLETED · started Jan 30, 2023ClinicalTrials.gov NCT05724693 · fetched Nov 12, 2026
- SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19PHASE3 · COMPLETED · started Nov 25, 2022ClinicalTrials.gov NCT05629962 · fetched Nov 12, 2026
- Study of AT-752 in Healthy Subjects in a Dengue Human Challenge ModelPHASE1 · TERMINATED · started Apr 22, 2022ClinicalTrials.gov NCT05366439 · fetched Nov 12, 2026
- Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)PHASE1 · COMPLETED · started Jul 28, 2021ClinicalTrials.gov NCT05004415 · fetched Nov 12, 2026
- Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital SettingPHASE2 · TERMINATED · started May 26, 2020ClinicalTrials.gov NCT04396106 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jan 8, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 12, 2025 · fetched Nov 12, 2026